@AgeneBio

AgeneBio develops innovative therapeutics that prevent neurodegeneration and preserves cognitive function.

 Baltimore, MD
agenebio.com
Joined October 2014
  • Tweets47
  • Following38
  • Followers124
AgeneBio founder Michela Gallagher to speak on emerging #Alzheimers therapies at @ASENT_Org 2018 Annual Meeting bit.ly/2BX7dLZ
2
AgeneBio founder Michela Gallagher to speak at 2018 @NIH #Alzheimers Research Summit on March 2 bit.ly/2BWjIY6 #ADSummit18
2
AgeneBio receives NIH grant to initiate Phase 3 HOPE4MCI trial to treat MCI due to #Alzheimers disease bit.ly/2f7DkMe
2
7
AgeneBio receives up to $10M in NIH funding to advance program for mild cognitive impairment due to #alzheimers bit.ly/2xZqmrl
1
2
Thanks 2 @TheADDF 4 another grant--will fund GABA-A drug-discovery program to delay onset of #Alzheimers dementia bit.ly/2ty3l0u
8
3
12
Our new corporate presentation is loaded on agenebio.com/investor-relati… #Alzheimers
1
CEO Jerry McLaughlin presenting today at 3:35pm in NYC @ Neuroscience BioPartnering & Investment Forum bit.ly/218rx0P #Alzheimers
Looking fwd 2 tomorrow's Neuroscience BioPartnering & Investment Forum CEO Jerry McLaughlin to present bit.ly/218rx0P #Alzheimers
CEO Jerry McLaughlin 2 present @ Neuroscience BioPartnering & Investment Forum bit.ly/218rx0P #Alzheimer #Phase3 #aMCI
Looking forward 2 @IAmBiotech CEO & Investor Conf our CEO on tap Feb 8 10:15am NYC bit.ly/1SVPPcL #alzheimers #phase3
AgeneBio CEO Jerry McLaughlin to present at @IAmBiotech CEO & Investor Conf Feb 8 10:15am NYC bit.ly/1SVPPcL #alzheimers #phase3
1
1
We've shared a new corporate deck on agenebio.com and on SlideShare slideshare.net/AgeneBio #Alzheimers

Home - AgeneBio

Our MissionTo discover and develop innovative therapeutics for patients at risk for neurological and psychiatric conditions, benefiting the lives of patient ...

agenebio.com
Check out the new @AgeneBio Phase 3 #clinicaltrial website for prevention/delay of #Alzheimers/#dementia: HOPE4MCI.org/

HOPE4MCI Clinical Research Trial for Patients Diagnosed with aMCI

HOPE4MCI is a research study for patients diagnosed with aMCI—or amnestic mild cognitive impairment.

hope4mci.org
3
3
AgeneBio launches new HOPE4MCI.org/ Phase 3 clinical website for prevention/delay of Alzheimer’s dementia #Alzheimers

HOPE4MCI Clinical Research Trial for Patients Diagnosed with aMCI

HOPE4MCI is a research study for patients diagnosed with aMCI—or amnestic mild cognitive impairment.

hope4mci.org
1
2
We've shared a new corporate deck on our agenebio.com and on SlideShare slideshare.net/AgeneBio #Alzheimers

Home - AgeneBio

Our MissionTo discover and develop innovative therapeutics for patients at risk for neurological and psychiatric conditions, benefiting the lives of patient ...

agenebio.com
Thanks, Ian. Excited to be a member of @LEAD_Coalition. xitter.cf/LEAD_Coalition/status/…
Ian Kremer@LEAD_Coalition9 Dec 2015
Thrilled to welcome our newest member organizations: @SecondWindDream @n4aACTION @AgeneBio! #dementia #Alzheimers #caregiving #innovation
2
We welcome the distinguished Dr. Richard Mohs as our VP, Clinical Development for #Alzheimer's Phase3 HOPE4MCI trial bit.ly/1IRz8GJ
1
.@alzforum reviews our own Dr. Gallagher's CTAD session on new #Alzheimers Phase 3 #clinicaltrials bit.ly/21fGUWm
1
AgeneBio CEO Jerry McLaughlin to present @ Future of Innovation in Medicine Conference @gatesfoundation bit.ly/1N6oGvI #Alzheimers
1
AgeneBio to Present as a Top Project to Watch: Most Licensable Products in Neuroscience @ TAP Conference bit.ly/1MDV50W #Alzheimers
1
Load more